Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice

Biologicals

Volumn 36, Issue 5, 2008, Pages 287-295

  Little, S F ^a   Webster, W M ^a   Wilhelm, H ^a   Powell, B ^a   Enama, J ^a   Adamovicz, J J ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Enzyme linked immunosorbent assay; Plague; Potency assay; Recombinant F1 V vaccine; Yersinia pestis

Indexed keywords

BACTERIAL PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PLAGUE VACCINE; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROLOGY; SWISS WEBSTER MOUSE; VACCINATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; MICE; PLAGUE VACCINE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SUBSTRATE SPECIFICITY;

MUS; YERSINIA PESTIS;

EID: 50349100571     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2008.03.001     Document Type: Article

References (37)

1. Baker E.E., Sommer H., Foster L.E., Meyer E., and Meyer K.F. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol 68 (1952) 131-145
2. Andrews G.P., Heath D.G., Anderson Jr. G.W., Welkos S.L., and Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64 (1996) 2180-2187
3. Williams Jr. R.C., Gewurz H., and Quie P.G. Effects of Fraction I from Yersinia pestis on phagocytosis in vitro. Infect Dis 126 (2007) 235-241
4. Worsham P.L., Stein M.-P., and Welkos S.L. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib Microbiol Immunol 13 (1995) 325-328
5. Welkos S.L., Davis K.M., Pitt L.M., Worsham P.L., and Friedlander A.M. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib Microbiol Immunol 13 (1995) 299-305
6. Friedlander A.M., Welkos S.L., Worsham P.L., Andrews G.P., Heath D.G., Anderson Jr. G.W., et al. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 21 (1995) S178-S181
7. Davis K.J., Fritz D.L., Pitt M.L., Welkos S.L., Worsham P.L., and Friedlander A.M. Pathology of experimental pneumonic plague produced by Fraction 1-positive and Fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 120 (1996) 156-163
8. Anderson Jr. G.W., Worsham P.L., Bolt C.R., Andrews G.P., Welkos S.L., Friedlander A.M., et al. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am J Trop Med Hyg 56 (1997) 471-473
9. Burrows T.W., and Bacon G.A. The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol 37 (1956) 481-493
10. Leary S.E., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun 63 (1995) 2854-2858
11. Nilles M.L., Fields K.A., and Straley S.C. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol 180 (1998) 3410-3420
12. Welkos S., Friedlander A., McDowell D., Weeks J., and Tobery S. V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 24 (1998) 185-196
13. Nakajima R., Motin V.L., and Brubaker R.R. Suppression of cytokines in mice by Protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63 (1995) 3021-3029
14. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196 (2002) 1017-1024
15. Meyer K.F. Effectiveness of live or killed plague vaccines in man. Bull WHO 42 (1970) 635-666
16. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E.C., et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 12 (1995) 223-230
17. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 (1997) 1079-1084
18. Anderson Jr. G.W., Heath D.G., Bolt C.R., Welkos S.L., and Friedlander A.M. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am J Trop Med Hyg 58 (1998) 793-799
19. Heath D.G., Anderson Jr. G.W., Mauro J.M., Welkos S.L., Andrews G.P., Adamovicz J., et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16 (1998) 1131-1137
20. Powell B.S., Andrews G.P., Enama J.T., Jendrek S., Bolt C., Worsham P., et al. Design and testing for a non-tagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 21 (2005) 1490-1510
21. Simpson W.J., Thomas R.E., and Schwan T.G. Recombinant capsular antigen (Fraction 1) from Yersinia pestis induces a protective antibody response in BLAB/c mice. Am J Trop Med Hyg 43 (1990) 389-396
22. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and Protein A-V antigen fusion peptide. Infect Immun 62 (1994) 4192-4201
23. Hill J., Leary S.E.C., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65 (1997) 4476-4482
24. Chen T.H., Foster L.E., and Meyer K.F. Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with a vaccine prepared with killed virulent whole organisms. J Immunol 87 (1961) 64-71
25. von Metz E., Eisler D.M., and Hottle G.A. Immunogenicity of plague vaccines in mice and guinea pigs. Appl Microbiol 22 (1971) 84-88
26. Chen T.H., Foster L.E., and Meyer K.F. Comparison of the immune response to three different Yersinia pestis vaccines in guinea pigs and langurs. J Infect Dis 129 (1974) S53-S61
27. Lacy M.J., and Voss Jr. E.W. A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells. J Immunol Methods 87 (1986) 169-177
28. Plikaytis B.D., Holder P.F., Pais L.B., Maslanka S.E., Gheesling L.L., and Carlone G.M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 32 (1994) 2441-2447
29. Bliss C.I. Statistics in biology: statistical methods for research in the natural sciences. Linear regression (1967), McGraw-Hill, New York p. 152-185
30. Une T., and Brubaker R.R. Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol 133 (1984) 2226-2230
31. Yahr T.L., Mende-Mueller L.M., Friese M.B., and Frank D.W. Identification of Type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 179 (1997) 7165-7168
32. Goure J., Broz P., Attree O., Cornelis G.R., and Attree I. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis 192 (2005) 218-225
33. Burr S.E., Stuber K., Wahli T., and Frey J. Evidence for a Type III secretion system in Aeromonas salmonicida subst. salmonicida. J Bacteriol 184 (2002) 5966-5970
34. Burr S.E., Stuber K., and Frey J. The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a Type III secretion pathway. J Bacteriol 185 (2003) 6583-6591
35. Habig W.H. Potency testing of bacterial vaccines for human use. Vet Microbiol 37 (1993) 343-351
36. Smith H., and Packman L.P. A filtered non-toxic plague vaccine which protects guinea-pigs and mice. Br J Exp Pathol 47 (1966) 25-34
37. Goodin J.L., Nellis D.F., Powell B.S., Vyas V.V., Enama J.T., Wang L.C., et al. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Prot Exp Purif 53 (2007) 63-79